Weekly newsletter

The first shipment of the Oxford-AstraZeneca vaccine, which has been approved by the European Medicines Agency, arrived in Hungary on Saturday, public news channel M1 said.

The shipment containing enough vaccine to inoculate 20,000 people was received by Hungaropharma on Saturday morning, M1 said. The vaccine is planned to be used to inoculate persons with underlying conditions aged under 60 who have registered for vaccination.

The AstraZeneca vaccine was approved by Hungary’s National Institute of Pharmacy and Nutrition before the European Medicines Agency.

Everything You Need to Know About the Oxford-AstraZeneca Vaccine
Everything You Need to Know About the Oxford-AstraZeneca Vaccine

Hungary’s National Institute of Pharmacy and Nutrition (OGYÉI) has authorized the use of the Oxford-AstraZeneca Vaccine, making Hungary the first European Union member state to allow its use. Here is what you need to know. Oxford university and AstraZeneca’s vaccine is already being used in the United Kingdom, and the EU’s licensing authorities have stated […]Continue reading

The advantage of the AstraZeneca vaccine is that it can be stored and transported at temperatures between 2 and 8 degrees Celsius, which makes it easier to handle than the vaccines previously available.

Two jabs are needed to achieve immunity, the second to be administered 4-12 weeks after the first.

Hungary has signed up for 6,540,000 doses of the AstraZeneca vaccine, which is enough to inoculate 3,270,000 people, M1 said.

Featured photo by Zoltán Máthé/MTI